Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: Thailand Medical News  Jan 02, 2020  4 years, 1 month, 3 weeks, 2 days, 9 hours, 40 minutes ago

Machine Learning Platforms Generates More Alerts For Drug Errors

Machine Learning Platforms Generates More Alerts For Drug Errors
Source: Thailand Medical News  Jan 02, 2020  4 years, 1 month, 3 weeks, 2 days, 9 hours, 40 minutes ago
A new machine learning platform can generate clinically valid alerts for medication errors that might be missed with existing clinical decision support (CDS) systems, according to a study published in the January issue of The Joint Commission Journal on Quality and Patient Safety.



Dr Ronen Rozenblum, Ph.D., M.P.H., from Harvard Medical School in Boston, and colleagues examined the ability of a machine learning system (MedAware) to generate clinically valid alerts, and estimated the associated cost savings with potentially prevented adverse events. Alerts were generated on outpatient data from two academic medical centers between 2009 and 2013. MedAware alerts were compared with those in an existing CDS system.

The medical researchers found that 10,668 alerts were generated. Using the existing CDS system, 68.2 percent of MedAware alerts would not have been generated. Based on structured data available in the record, 92 percent of a random sample of 300 chart-reviewed alerts were accurate; 79.7 percent were clinically valid. Potentially prevented adverse events had an estimated cost of more than $60 per drug alert in an outpatient setting and US $1.3 million when extending findings to the full patient population.

Dr Rozenblum told Thailand Medical News via a telephone interview, "The true value of such alerts is highly contingent on whether and how clinicians respond to such alerts and their potential to prevent actual patient harm."

The study was funded by Becton Dickinson. Several authors disclosed financial ties to the medical device and medical technology industries.

Reference:  Clinical and Cost Analysis EvaluationRonen Rozenblum,Rosa Rodriguez-Monguio, Lynn A. Volk, Katherine J. Forsythe et al. DOI: https://doi.org/10.1016/j.jcjq.2019.09.008
 

MOST READ

Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19